No black box warning on record for Betamethasone Dipropionate

As of the latest FDA labeling reviewed, Betamethasone Dipropionate (BETAMETHASONE DIPROPIONATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Betamethasone Dipropionate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Effects on endocrine system: Betamethasone dipropionate cream (augmented) can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of treatment. Risk factor(s) include the use of high-potency topical corticosteroids, use over a large surface area or to areas under occlusion, prolonged use, altered skin

No black box warning on record for Betamethasone Dipropionate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Effects on endocrine system: Betamethasone dipropionate cream (augmented) can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of treatment. Risk factor(s) include the use of high-potency topical corticosteroids, use over a large surface area or to areas under occlusion, prolonged use, altered skin

Betamethasone Dipropionate Black Box Warning

No black box warning on record for Betamethasone Dipropionate

Other warnings & precautions

Betamethasone Dipropionate Black Box Warning

No black box warning on record for Betamethasone Dipropionate

Other warnings & precautions